No Data
Lumos Diagnostics Updates Director Doug Ward's Expanded Equity Holding
Lumos Ramps up U.S. Rollout of FebriDx Ahead of Investor Briefing
Lumos Diagnostics Progresses Additional Pilot Sites With Urgent Care Operators For Respiratory Infection Testing Tool, Shares Jump 4%
Lumos Sees Strong Early Reimbursement Signals as FebriDx Rollout Gains Traction in US Urgent Care Market | ASX:LDX, OTC:LDXHF
Small Cap Watch: Small Caps Mixed as Elixir, Ora Banda, Lumos and Scorpion Deliver Key Updates | ASX:EXR, OTC:ELXPF
Lumos Diagnostics Hits Enrollment Milestone in Pediatric Clinical Study of Respiratory Infection Testing Tool; Shares Down 4%